Secukinumab Reduces Endothelial Dysfunction in Subjects with Moderate-to-Severe Plaque Psoriasis Over 52 Weeks: Results of the Exploratory CARIMA Study. J of Skin [Internet]. 2018 Feb. 23 [cited 2025 Apr. 19];2(S1):S20. Available from: https://skin.dermsquared.com/skin/article/view/290